Synbiotics as Supplemental Therapy for the Alleviation of Chemotherapy-Associated Symptoms in Patients with Solid Tumours

Chemotherapy is still the first line of treatment for most cancer patients. Patients receiving chemotherapy are generally prone to infections, which result in complications, such as sepsis, mucositis, colitis, and diarrhoea. Several nutritional approaches have been trialled to counter the chemotherapy-associated side effects in cancer patients, but none have yet been approved for routine clinical use. One of the approaches to reduce or avoid chemotherapy-associated complications is to restore the gut microbiota. Gut microbiota is essential for the healthy functioning of the immune system, metabolism, and the regulation of other molecular responses in the body. Chemotherapy erodes the mucosal layer of the gastrointestinal tract and results in the loss of gut microbiota. One of the ways to restore the gut microbiota is through the use of probiotics. Probiotics are the 'good' bacteria that may provide health benefits if consumed in appropriate amounts. Some studies have highlighted that the consumption of probiotics in combination with prebiotics, known as synbiotics, may provide better health benefits when compared to probiotics alone. This review discusses the different nutritional approaches that have been studied in an attempt to combat chemotherapy-associated side effects in cancer patients with a particular focus on the use of pre-, pro- and synbiotics.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:15

Enthalten in:

Nutrients - 15(2023), 7 vom: 04. Apr.

Sprache:

Englisch

Beteiligte Personen:

Singh, Neeraj K [VerfasserIn]
Beckett, Jeffrey M [VerfasserIn]
Kalpurath, Krishnakumar [VerfasserIn]
Ishaq, Muhammad [VerfasserIn]
Ahmad, Tauseef [VerfasserIn]
Eri, Rajaraman D [VerfasserIn]

Links:

Volltext

Themen:

Cancer
Chemotherapy
Journal Article
Prebiotics
Probiotics
Review
Synbiotics

Anmerkungen:

Date Completed 14.04.2023

Date Revised 15.04.2023

published: Electronic

Citation Status MEDLINE

doi:

10.3390/nu15071759

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM355539594